Drug Trial Radar · NCT03129646
Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
Last checked: Nov 20, 2026Latest source record: Feb 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
439
Actual
Start
Jan 24, 2018
Primary completion
Dec 11, 2020
Study completion Dec 11, 2020
Sponsor
- Lead sponsor
- Drugs for Neglected DiseasesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Netherlands Cancer Institute; The Institute of Endemic Diseases (IEND), University of Khartoum; Kenya Medical Research Institute; Makerere University; University of Gondar
- First posted
- Apr 26, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 4 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open label, Phase III, randomized, controlled, parallel arm multicentre non-inferiority clinical trial to compare the efficacy and safety of two combination regimens of Miltefosine and Paromomycin with the standard SSG-PM for the treatment of primary adult and children VL patients in Eastern Africa.
Conditions
- Visceral Leishmaniasis
Interventions
MiltefosineDrug
Miltefosine 10mg and 50mg capsules
ParomomycinDrug
Paromomycin sulfate equiv to 750mg paromomycin / 2ml amp
Sodium stibogluconateDrug
Sodium stibogluconate 33% 30 ml inj.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Definitive CureTime frame: 6 months follow-up (Day 210)
Locations
7 sites in 4 countries. Site status is shown where the registry gives one.
University Hospital of Gondar
Gonder, Ethiopia
Abdurafi MSF Health Center
Ābderafī, Amhara, Ethiopia
Kacheliba Hospital
Kapenguria, West Pokot County, Kenya
Um El Kher Hospital
Gedaref, Sudan
El Hassan Centre for Tropical Medicine
Doka, Al Qaḑārif, Sudan
Tabarak Allah MSF Hospital
Gedaref, Al Qaḑārif, Sudan
Amudat Hospital
Amudat, Karamoja, Uganda
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.